risks of microdosing glp 1 GLP-1 Microdosing: Risks, Benefits and What to Know Before Changing Your Dose People Are Microdosing Weight-Loss Drugs

Mistake 5: Not consulting a healthcare provider

However, unlike FDA-approved GLP-1 medications, these patches arent regulated to the same public safety standards, and the claims made by manufacturers are not backed by the same degree of rigorous clinical trials

These compounded GLP-1 drugs may include custom microdose formulations, and some are marketed for off-label uses like longevity or cognitive support, though experts warn that their safety and effectiveness remain unproven

2024;2(6):qxae055

Hyperinsulinemia and metabolic inflammation

But the same industry group that sued the FDA for the tirzepatide change also just sued the agency for removing semaglutide from its shortage list on essentially the same groundsthat they had dismissed evidence that the drug is still in short supply